It was reported that phosphorylated MAPKs including ERK2 (MAPK1), JNK1 (MAPK8) and p38 MAPK (MAPK14) over-expressed in breast cancer patients and is associated with poor prognosis [41–43]. Here, MAPK1 is linked to breast cancer.